eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | barrett esophagus |
| Comorbidity | C0014859|esophageal cancer |
| Sentences | 6 |
| PubMedID- 25097676 | Interesting results were published by the authors applying emr as a stepwise radical endoscopic resection (srer) of esophageal lesions to eradicate barrett's esophagus with early-stage esophageal cancer. |
| PubMedID- 23600048 | Prevalence of extra-esophageal cancers in patients with barrett's esophagus and esophageal adenocarcinoma. |
| PubMedID- 22449575 | Immortal person-time bias in relation to the use of nonsteroidal anti-inflammatory drugs and statins in the prevention of esophageal cancer in patients with barrett's esophagus. |
| PubMedID- 22891079 | (10), which suggested that use of statins for more than 12 months can correlate with 48% risk reduction of esophageal cancer in patients with barrett's esophagus (95% ci 0.30–0.91) (10). |
| PubMedID- 23357487 | Statins are associated with reduced risk of esophageal cancer, particularly in patients with barrett's esophagus: a systematic review and meta-analysis. |
| PubMedID- 24340253 | Six common types of cancer, including barrett esophagus associated with esophageal cancer, breast cancer, colon cancer, hepatocellular carcinoma, gastric cancer, and thyroid carcinoma, have been probed with maldi-ims by meding and walch.18 patient diagnosis begins with the identification of tumor origin and tumor classification; when a primary tumor cannot be identified, cancer of unknown primary site is diagnosed. |
Page: 1